default author photo

Sally Pearson

QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory

Herston, Queensland

Australia

SCHOLARLY PAPERS

1

DOWNLOADS

69

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8 + T Cells

Number of pages: 75 Posted: 10 Oct 2019
QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Oncology and Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute - Gordon and Jessie Gilmour Leukemia Laboratory, University of Bonn - Institute of Experimental Oncology, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, Bristol Myers Squibb - Immuno-Oncology Discovery, Institut de recherches cliniques de Montréal (IRCM) - Laboratory of Molecular Oncology, University of Bonn - Institute of Experimental Oncology, University of Queensland - Pathology Queensland, The University of Sydney - Melanoma Institute Australia, The University of Sydney - Melanoma Institute Australia, The University of Sydney - Melanoma Institute Australia, University of Queensland - Royal Brisbane and Women’s Hospital, QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory, Bristol Myers Squibb - Immuno-Oncology Discovery, University of Toulouse 3, Paul Sabatier University - Cancer Research Center of Toulouse (CRCT), QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory and QIMR Berghofer Medical Research Institute - Immunology in Cancer and Infection Laboratory
Downloads 69 (883,195)

Abstract:

Loading...

Dysfunctional CD8+ T cells, CD226 (DNAM-1), CD155 (PVR), Cancer immunotherapy, Melanoma, HNSCC, adoptive cell transfer therapy